Hashimoto encephalopathy with high plasma monoamine metabolite levels: a case report
Sho Horikoshi,1,2 Itaru Miura,2 Yasuto Kunii,3 Satoko Asano,4 Keiko Kanno-Nozaki,2 Hirobumi Mashiko,5 Hirooki Yabe2 1Department of Neuropsychiatry, Hoshi General Hospital, 2Department of Neuropsychiatry, Fukushima Medical University School of Medicine, 3Department of Neuropsychiatry, Fukushima Medi...
Guardado en:
Autores principales: | Horikoshi S, Miura I, Kunii Y, Asano S, Kanno-Nozaki K, Mashiko H, Yabe H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b49fe687ec7d4281900f9a81ac53603a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EVALUATION OF CLINICAL SYMPTOMATOLOGY IN PATIENTS WITH HASHIMOTO'S ENCEPHALOPATHY AND ASSOCIATION WITH UNDERLING THYROID DISEASE
por: Asif Hashmat, et al.
Publicado: (2019) -
Tiroiditis crónica de Hashimoto: Serie clínica
por: PIRAINO N,PATRICIA, et al.
Publicado: (2010) -
Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
por: Ichinose M, et al.
Publicado: (2021) -
Monoamine Oxidase-B Inhibitor Reduction in Pro-Inflammatory Cytokines Mediated by Inhibition of cAMP-PKA/EPAC Signaling
por: Edward E. Putnins, et al.
Publicado: (2021) -
Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode
por: Kurita M
Publicado: (2016)